Abstract
Drugs like salicylate and chloramphenicol have been shown experimentally to induce congenital malformations in animals (1). In addition, salicylate is suspected of producing malformations in the human fetus (2). Our main interest in these agents has been to elucidate the hemolytic mechanism they induce in sensitive enzyme-deficient cells. Although the biochemistry of the erythrocyte varies in some respects from the biochemistry of other cells, our data on modification of erythrocyte enzyme activities may well be relevant also to other tissues.
Full Text
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call